{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:57:31Z","timestamp":1781308651973,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015359","name":"Shanghai Medical College of Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2310602"],"award-info":[{"award-number":["2024YFC2310602"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128509","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:27:07Z","timestamp":1774294027000},"page":"128509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cost-effectiveness of hepatitis A vaccination for adults in China: A decision tree Markov model study"],"prefix":"10.1016","volume":"79","author":[{"given":"Aodi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zundong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9116","key":"10.1016\/j.vaccine.2026.128509_bb0005","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0140-6736(98)01304-X","volume":"351","author":"Koff","year":"1998","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128509_bb0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4254\/wjh.v4.i3.68","article-title":"Hepatitis a: epidemiology and prevention in developing countries","volume":"4","author":"Franco","year":"2012","journal-title":"World J Hepatol"},{"key":"10.1016\/j.vaccine.2026.128509_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2017.08.034","article-title":"Type a viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention","volume":"68","author":"Lemon","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2026.128509_bb0020","first-page":"227","article-title":"Hepatitis a and B superimposed on chronic liver disease: vaccine-preventable diseases","volume":"117","author":"Keeffe","year":"2006","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128509_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128509_bb0030","first-page":"1528","article-title":"Epidemiological characteristics and spatiotemporal clustering of hepatitis a in China, 2005-2023","volume":"45","author":"Xiu","year":"2024","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128509_bb0035","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40249-019-0591-z","article-title":"Changes in the epidemiology of hepatitis a in three socio-economic regions of China, 1990-2017","volume":"8","author":"Sun","year":"2019","journal-title":"Infect Dis Poverty"},{"issue":"30","key":"10.1016\/j.vaccine.2026.128509_bb0040","doi-asserted-by":"crossref","first-page":"570","DOI":"10.46234\/ccdcw2020.152","article-title":"An epidemic of Hepatitis a - Liaoning Province, 2020","volume":"2","author":"Sun","year":"2020","journal-title":"China CDC Wkly"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128509_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2106081","article-title":"A community-wide epidemic of hepatitis a virus genotype IA associated with consumption of shellfish in Yantai, eastern China, January to march 2020","volume":"18","author":"Yan","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128509_bb0050","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.31429","article-title":"Changing epidemiology of Hepatitis a in China: evidence from three National Serological Surveys and the National Notifiable Disease Reporting System","volume":"73","author":"Wang","year":"2021","journal-title":"Hepatology"},{"issue":"02","key":"10.1016\/j.vaccine.2026.128509_bb0055","first-page":"138","article-title":"The economic burden of and quality of life with vaccine-preventable diseases targeted by expanded program on immunization vaccines in several areas of China: a retrospective survey","volume":"29","author":"Wang","year":"2023","journal-title":"Chin J Vaccine Immun"},{"issue":"42","key":"10.1016\/j.vaccine.2026.128509_bb0060","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1016\/j.vaccine.2012.07.049","article-title":"Cost-effectiveness of hepatitis a vaccination for adults in Belgium","volume":"30","author":"Luyten","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128509_bb0065","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.vaccine.2019.01.070","article-title":"Economic evaluation of a publicly funded hepatitis a travel vaccination program in Ontario, Canada","volume":"37","author":"Ramsay","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128509_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0306293","article-title":"Cost-effective analysis of hepatitis a vaccination in Kerala state, India","volume":"19","author":"Gurav","year":"2024","journal-title":"PLoS ONE"},{"issue":"35","key":"10.1016\/j.vaccine.2026.128509_bb0075","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1016\/j.vaccine.2008.05.086","article-title":"A cost-effectiveness analysis of universal childhood hepatitis a vaccination in China","volume":"26","author":"Zhuang","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128509_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated health economic evaluation reporting standards (CHEERS)\u2014explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2026.128509_bb0085","unstructured":"WHO. WHO guide for standardization of economic evaluations of immunization programmes. 2nd ed. Date: 2019. Date accessed: July 21. 2025. Available from: https:\/\/www.who.int\/publications\/i\/item\/who-guide-for-standardization-of-economic-evaluations-of-immunization-programmes-2nd-ed."},{"key":"10.1016\/j.vaccine.2026.128509_bb0090","unstructured":"W. Bank. Official exchange rate. Date: 2024. Date accessed: July 21 2025. Available from: https:\/\/data.worldbank.org\/indicator\/PA.NUS.FCRF?locations=CN."},{"key":"10.1016\/j.vaccine.2026.128509_bb0095","unstructured":"W. Bank. Inflation, consumer prices (annual %) - China. Date: 2024. Date accessed: July 21. 2025. Available from: https:\/\/data.worldbank.org\/indicator\/FP.CPI.TOTL.ZG?locations=CN."},{"issue":"1","key":"10.1016\/j.vaccine.2026.128509_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41572-023-00461-2","article-title":"Hepatitis a virus infection","volume":"9","author":"Van Damme","year":"2023","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128509_bb0105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1542\/peds.109.5.839","article-title":"Hepatitis a virus infections in the United States: model-based estimates and implications for childhood immunization","volume":"109","author":"Armstrong","year":"2002","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128509_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037473","article-title":"Systematic review of the global epidemiology of viral-induced acute liver failure","volume":"10","author":"Patterson","year":"2020","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128509_bb0115","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031708","article-title":"Natural history, clinical manifestations, and pathogenesis of hepatitis A","volume":"8","author":"Shin","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128509_bb0120","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-127-10-199711150-00001","article-title":"Estimates of the cost-effectiveness of a single course of interferon-\u03b12b in patients with histologically mild chronic hepatitis C","volume":"127","author":"Bennett","year":"1997","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128509_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12876-024-03249-0","article-title":"The burden and predictors of 30-day unplanned readmission in patients with acute liver failure: a national representative database study","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Gastroenterol"},{"issue":"01","key":"10.1016\/j.vaccine.2026.128509_bb0130","first-page":"54","article-title":"Characteristic distribution of 860 liver transplant patients","volume":"25","author":"Zhang","year":"2024","journal-title":"Chin Med Rec"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128509_bb0135","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1016\/S2468-2667(25)00039-8","article-title":"Health impact and economic evaluation of the expanded program on immunization in China from 1974 to 2024: a modelling study","volume":"10","author":"Wang","year":"2025","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.vaccine.2026.128509_bb0140","unstructured":"Procurement CG. Announcement of Winning Bidders for the 2025 National Immunization Program Vaccine Centralized Procurement Project. Date: Jan 25, 2025. Date accessed: July 22. 2025. Available from: https:\/\/www.ccgp.gov.cn\/cggg\/zygg\/zbgg\/202501\/t20250124_24113357.htm."},{"issue":"3","key":"10.1016\/j.vaccine.2026.128509_bb0145","article-title":"Procurement of category 2 vaccines in China","volume":"7","author":"Zhuang","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"21","key":"10.1016\/j.vaccine.2026.128509_bb0150","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.vaccine.2018.04.008","article-title":"Routine immunization services costs and financing in China, 2015","volume":"36","author":"Yu","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128509_bb0155","first-page":"1","article-title":"The meta analysis of protective efficacy of attenuated live hepatitis a vaccine","volume":"01","author":"Wang","year":"2008","journal-title":"Chin J Vacc Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128509_bb0160","article-title":"Hepatitis a immunisation in persons not previously exposed to hepatitis a","volume":"2019","author":"Patterson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"10.1016\/j.vaccine.2026.128509_bb0165","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jama.1994.03510410040030","article-title":"Protection against hepatitis a by an inactivated vaccine","volume":"271","author":"Innis","year":"1994","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128509_bb0170","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cmi.2018.11.005","article-title":"Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV study","volume":"25","author":"Luo","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2026.128509_bb0175","series-title":"China statistics yearbook 2023","author":"Department of Population and Employment Statistics NBoSoC","year":"2023"},{"key":"10.1016\/j.vaccine.2026.128509_bb0180","series-title":"WHO guide for standardization of economic evaluations of immunization programmes. WHO guide for standardization of economic evaluations of immunization programmes","author":"Organization WH","year":"2019"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128509_bb0185","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S0022172400062859","article-title":"The estimation of age-related rates of infection from case notifications and serological data","volume":"95","author":"Grenfell","year":"1985","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2026.128509_bb0190","series-title":"China population census yearbook 2020","author":"Census OotLGotSCftSNP","year":"2024"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128509_bb0195","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.vaccine.2009.06.035","article-title":"WHO guide for standardisation of economic evaluations of immunization programmes","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2026.128509_bb0200","doi-asserted-by":"crossref","first-page":"591","DOI":"10.46234\/ccdcw2020.158","article-title":"Progress towards Hepatitis a control and prevention through 2019: the National Immunization Program of China","volume":"2","author":"Sun","year":"2020","journal-title":"China CDC Wkly"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128509_bb0205","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/21645515.2018.1529128","article-title":"Changing epidemiological characteristics of Hepatitis a and warning of anti-HAV immunity in Beijing, China: a comparison of prevalence from 1990 to 2017","volume":"15","author":"Wang","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128509_bb0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2019.03.005","article-title":"Changes in seroprevalence of hepatitis a after the implementation of universal childhood vaccination in Shandong Province, China: a comparison between 2006 and 2014","volume":"82","author":"Yan","year":"2019","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128509_bb0215","first-page":"712","article-title":"Working Committee of Promoting the elimination of viral Hepatitis of Chinese preventive medicine a, Society of P, control of infectious diseases of Chinese preventive medicine a. [expert recommendations on hepatitis B vaccination in adults]","volume":"32","year":"2024","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128509_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/v13101900","article-title":"Hepatitis A: epidemiology, high-risk groups, prevention and research on antiviral treatment","volume":"13","author":"Migueres","year":"2021","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128509_bb0225","first-page":"862","article-title":"Cost-utility analysis on universal childhood hepatitis a vaccination in regions with different anti-HAV prevalence rates of China","volume":"33","author":"Pan","year":"2012","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:51:49Z","timestamp":1781308309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26003178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":45,"alternative-id":["S0264410X26003178"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128509","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of hepatitis A vaccination for adults in China: A decision tree Markov model study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128509"}}